GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Pre-Tax Income

Apollomics (Apollomics) Pre-Tax Income : $-172.59 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Apollomics's pretax income for the six months ended in Dec. 2023 was $-21.91 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-172.59 Mil. Apollomics's pretax margin was %.

Apollomics Pre-Tax Income Historical Data

The historical data trend for Apollomics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Pre-Tax Income Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-74.91 -94.80 -240.81 -172.59

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial -28.31 -3.42 -237.39 -150.68 -21.91

Competitive Comparison of Apollomics's Pre-Tax Income

For the Biotechnology subindustry, Apollomics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollomics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apollomics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Apollomics's Pre-Tax Income falls into.


Apollomics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Apollomics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-54.37+-118.824+-0.15+0.753+0
=-172.59

Apollomics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-28.2+6.003+-0.09+0.38+0
=-21.91

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-172.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics  (NAS:APLMW) Pre-Tax Income Explanation

Apollomics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-21.907/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Apollomics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Pre-Tax Income
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.